Christopher A Lamb Selected Research

N-(2-cyanoethylene)urea (BA 1)

1/2023

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher A Lamb Research Topics

Disease

12	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2023 - 02/2016
10	Ulcerative Colitis 04/2024 - 07/2014
8	COVID-19 01/2023 - 01/2020
5	Infections 01/2023 - 01/2021
4	Crohn Disease (Crohn's Disease) 04/2024 - 11/2022
4	Enterocolitis 10/2022 - 01/2019
3	Breakthrough Infections 01/2023 - 01/2022
2	Neoplasms (Cancer) 01/2023 - 09/2021
2	Inflammation (Inflammations) 11/2018 - 03/2012
2	Starvation 01/2015 - 05/2012
1	Arthritis (Polyarthritis) 01/2023
1	Reinfection 01/2023
1	Pain (Aches) 01/2023
1	Ulcer 01/2023
1	Vitiligo 01/2023
1	Premature Birth (Birth, Premature) 10/2022
1	Colitis 06/2021
1	Iron Deficiencies 06/2021
1	Persistent Infection 01/2021
1	Intestinal Diseases (Diseases, Intestinal) 11/2020
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2019
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2018
1	Breast Neoplasms (Breast Cancer) 09/2014
1	Rheumatoid Arthritis 03/2012
1	Malnutrition (Nutritional Deficiencies) 08/2009

Drug/Important Bio-Agent (IBA)

8	IntegrinsIBA 01/2023 - 02/2016
5	vedolizumabIBA 12/2023 - 01/2021
5	Infliximab (Remicade)FDA Link 01/2023 - 01/2021
4	VaccinesIBA 01/2023 - 01/2021
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2012
3	Monoclonal AntibodiesIBA 01/2023 - 02/2016
3	etrolizumabIBA 11/2018 - 07/2014
2	SteroidsIBA 01/2023 - 11/2022
2	COVID-19 VaccinesIBA 01/2023 - 01/2022
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022 - 01/2021
2	Amino Acids FDA Link 01/2015 - 05/2012
2	Chemokine ReceptorsIBA 09/2014 - 03/2012
1	Opioid Analgesics (Opioids)IBA 01/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023
1	AntibodiesIBA 01/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023
1	LigandsIBA 01/2023
1	Immune Checkpoint ProteinsIBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	cyclopropapyrroloindoleIBA 01/2023
1	Prednisolone (Predate)FDA LinkGeneric 11/2022
1	Immunoglobulin A (IgA)IBA 10/2022
1	Secretory Immunoglobulin A (SIgA)IBA 10/2022
1	Prostaglandins AIBA 05/2022
1	OligosaccharidesIBA 12/2021
1	ferric maltolIBA 06/2021
1	ferrous sulfate FDA Link 06/2021
1	SodiumIBA 06/2021
1	Dextrans (Dextran)FDA Link 06/2021
1	tofacitinibIBA 01/2021
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021
1	Polysaccharides (Glycans)IBA 11/2020
1	EnzymesIBA 11/2020
1	Phosphatidylinositols (Phosphatidylinositol)IBA 10/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	ParaffinIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 11/2018
1	alpha E integrinsIBA 11/2018
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2018
1	integrin beta7IBA 12/2017
1	Granzymes (Granzyme)IBA 02/2016
1	GuanosineIBA 05/2012
1	ChemokinesIBA 03/2012

Therapy/Procedure

8	Therapeutics 04/2024 - 07/2014
3	Biological Therapy 12/2023 - 01/2023
3	Ambulatory Care (Outpatient Care) 01/2022 - 01/2020
2	Precision Medicine 04/2024 - 01/2022
2	Colectomy 01/2022 - 01/2021
1	Genomic Medicine 01/2023
1	Critical Care (Surgical Intensive Care) 08/2009